Endocrinologist Rinki Murphy reviews how to utilise the benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, including how to start them, alongside usual management strategies for type 2 diabetes
Suzanne Davis and Elizabeth Walker discuss the diagnosis and classification of epilepsy syndromes, and the indications and adverse effects of anti-seizure medications. They also review self-management and lifestyle issues for people with epilepsy
All medicines containing codeine were reclassified as prescription medicines on 5 November 2020. Clinical advisory pharmacists Linda Bryant and John Dunlop discuss reasons for this decision and provide tips for pharmacists to help patients with the transition
This article, by consultant neurologist John Mottershead, looks briefly at the aetiology, pathophysiology and diagnosis of multiple sclerosis before exploring the approaches for treating relapses and symptoms of MS. It also discusses current disease-modifying treatments in detail
This article, written by specialist dermatologist Louise Reiche, aims to help pharmacists better understand the pathogenesis of psoriasis, feel confident about the available treatment options and provide the best advice to patients
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes